Anti‐MMR Nb‐IMDQ conjugates led to an efficient drug delivery to the MMRhigh TAMs in vivo, inducing a repolarization of TAMs towards a pro‐inflammatory phenotype and an increase in anti‐tumor T‐cell responses, which cause a significant decline in tumor growth. Here, MRC1 is linked to neoplasm.